|

ACT Lung Health Intervention: Phase Two

RECRUITINGN/ASponsored by Dana-Farber Cancer Institute
Actively Recruiting
PhaseN/A
SponsorDana-Farber Cancer Institute
Started2025-11-04
Est. completion2026-09-30
Eligibility
Age50 Years – 80 Years
Healthy vol.Accepted
Locations2 sites

Summary

This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.

Eligibility

Age: 50 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Self-identify as either Chinese or Korean
* Speak either Korean, Mandarin, or English
* Eligible for LDCT screening (50-80 years of age and 20- pack-year smoking history)
* Currently smoking (i.e., having smoked within the prior 30 days),
* Currently have active health insurance coverage and a primary healthcare provider and
* Have access to a video-call device with internet or wireless connection.
* Eastern Cooperative Oncology Group functional status \<2
* Live in the United States for the next 12 months

Exclusion Criteria:

* Had LDCT screening done within the last 2 years.
* Hospitalization due to a serious mental illness (e.g., psychotic disorders) during the prior 6 months.
* Previous history of lung cancer.
* We will not include any of the following special populations:

  * Adults unable to consent.
  * Adults younger than 50 or older than 80 years
  * Individuals who are not yet adults (infants, children, teenagers)
  * Pregnant women
  * Prisoners

Conditions7

CancerLung CancerSmoking (Tobacco) AddictionSmoking BehaviorsSmoking CessationSmoking, CigaretteSmoking, Tobacco

Locations2 sites

Dana-Farber Cancer Institute
Boston, Massachusetts, 02115
Mary Cooley, PhD617-632-5096Mary_cooley@dfci.harvard.edu
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115
Mary Cooley, PhD617-632-5096Mary_cooley@dfci.harvard.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.